Please assess the completion status of the following clinical trial:

Trial Title: Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with myopic regression equal or more than 0.5 D with minimum age of 20 years,~* cylinder ≤ -1.00 D,~* corrected distance visual acuity (CDVA) of at least 20/40 were included.~Exclusion Criteria:~* Patients with a history of previous ocular surgery,~* keratoconus or any ectatic corneal disorder,~* keratoconus suspect by topography,~* preoperative corneal opacity,~* any corneal dystrophies,~* presence of pterygium,~* retinal disorders,~* collagen vascular disorders,~* diabetes mellitus,~* glaucoma,~* cataract,~* pregnancy,~* breast feeding~* systemic corticosteroid therapy were excluded.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control group (Type: PLACEBO_COMPARATOR): included patients who received artificial tear twice a day as control group.
- Timolol group (Type: EXPERIMENTAL): included the patients with myopic regression who received timolol 0.5% eye drop twice a day

Based on this trial design, predict the completion outcome and termination type (if applicable).